August 5 - Israeli drug company SciVac has developed a third-generation
vaccine for Hepatitis B, a virus that kills more than half a million
people each year. The company says the vaccine has the potential to stop
the disease in its tracks and is currently seeking approval for its use
in the United States and Europe. Elly Park reports.
Labels: drugs in development, vaccines